New Global Beauty & Wellbeing Report unveils Emotional Wellbeing as the True Face of Beauty
New proprietary research from Oriflame redefines beauty as a powerful driver of…
UEG Week 2025: Microplastics found to change gut microbiome in first human-sample study
BERLIN, Oct. 7, 2025 /PRNewswire/ -- New research presented today at UEG Week…
Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025
October 05, 2025 09:00 ET Â | Source: Spyre Therapeutics, Inc. WALTHAM, Mass.,…
HKUST Scientists Reveal Critical Impacts of a Chinese Genetic Risk Factor in Alzheimer’s Disease
HONG KONG, Oct. 2, 2025 /PRNewswire/ -- A landmark study conducted by…
Geopolitical Volatility Surges into Top 10 Business Risks for the First Time, Aon’s Global Study Finds
19th year of survey reveals cybersecurity remains top concern as workforce-related risks…
CeraVe and L’Oral Groupe Win Prestigious IFSCC Applied Research Award for Breakthrough Dandruff Study
New findings reveal critical microbial drivers, ethnic variations, and new pathways for…
LANZAJET AND KAZMUNAYGAS (KMG) ANNOUNCE KAZAKHSTAN’S FIRST SUSTAINABLE AVIATION FUEL PROJECT PASSES MAJOR MILESTONE AND ADVANCES TO ENGINEERING AND DESIGN PHASE
As part of New York Climate Week, LanzaJet's CEO addressed the President…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
EADV Congress 2025: Atopic eczema linked to significantly higher risk of suicidal thoughts
PARIS, Sept. 17, 2025 /PRNewswire/ -- A new international study presented today…
No Difference in Transplant Outcomes Seen for Patients Unlikely to Find a Matched Unrelated Donor When a Donor Search Prognosis Strategy is Used
Published in the Journal of Clinical Oncology, results showed no difference in…
